REGENEREX PHARMA, INC. Interest Paid, Excluding Capitalized Interest, Operating Activities
REGENEREX PHARMA, INC. reported Interest Paid, Excluding Capitalized Interest, Operating Activities of $0 for the 9-month period ending 2025-12-31, per its 10-KT filed 2026-08-31.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:InterestPaidNet · last filed 2026-08-31
- REGENEREX PHARMA, INC. interest paid, excluding capitalized interest, operating activities for fiscal 2025 was $27.57K.
| Period end | Interest Paid, Excluding Capitalized Interest, Operating Activities 9 month | Interest Paid, Excluding Capitalized Interest, Operating Activities 12 month |
|---|---|---|
| 2025-12-31 | $0.00 10-KT · filed 2026-08-31 | |
| 2025-03-31 | $27.57K 10-KT · filed 2026-08-31 |